Issue link: https://viewer.e-digitaledition.com/i/882038
Additional Applications THE E X PLORER TOTA L˜BODY PE T scanner's improved signal collec- tion capability opens the door to potential uses ranging far beyond oncology. According to the device's lead developers at the University of California, Davis, a few of those applications include: + Assessing the responses of patients with diabetes to pre - scribed exercise regimens + Identifying reservoirs of diseases such as AIDS + Examining maternal-fetal interac - tions to better understand how certain disorders develop in utero + Studying the brain/gut connection that could play a role in the devel - opment of obesity and diabetes + Following the paths and activities of cells used in regenerative medicine to refine self-heal - ing therapies Additionally, total-body PET may make it possible to follow the path of antibody and antibody- derived agents intended to treat cancer and inflammatory diseases through the body, as well as observe processes that take place concurrently in disparate parts of the body, according to Antonio Sastre, PhD, Program Director of the Division of Applied Science and Technology at the National Institute of Biomedical Imaging and Bioengineering. "The ability to track complex metabolic or physiologic pathways which may be taking place nearly simultaneously in different places in the body, such as activation of brown fat by a number of external or internal stressors, may open new perspectives in research," Sastre says. To solve that problem, the patient ne e d s t o b e s u r r ou nde d b y det e c - tors t hat ca n col lect a s much of t he radioactive tracer's signa l as possible, according to Cherr y. He a nd his col- leag ue, Ra msey Badawi, PhD, Chief of Nuclear Medicine at UC Davis Medica l Center and Professor of Radiolog y and Biomedica l Eng ineering at UC Davis, have developed a PET sca nner that is intended to do just that. A SURGE IN SIGNAL COLLECTION A f ter more tha n a decade of concep- tua lization, design and development, Cherr y a nd Badaw i have developed EXPLORER, a total-body PET scanner with a 6-foot gantry and 560,000 signal detectors — 10 times more than those featured in conventiona l machines, according to Cherr y. Shanghai-based United Imaging Hea lthcare produced a small-scale version of EXPLORER in early 2017 that is being used in anima l trials at UC Davis School of Veterinary Medicine. Cherr y and Badawi expect to begin human research trials in 2018. Conventiona l PET scanners require a patient to move through the scanner during a n exa m to ima ge the entire body. With EXPLORER, the patient will enter the bore and remain stationar y while the machine obtains a full-body i ma ge. Cher r y a nd Ba daw i pred ict EXPLOR ER will improve radiotracer signa l collection by a factor of 40 for a whole-body scan. " You could choose to use that entire factor of 40 to speed up the scan; you cou ld do a sca n of t he whole body in 1/40th of the time that we currently do t he sca n," Cher r y says. "A fa irly typica l 20-minute protocol could now be done in 30 seconds. You could use that factor-of-40 signa l collection in other ways, as well, or at least part of it. You could use it to reduce the injected dose ... or to collect more sig na l a nd get better-qua lity scans. You have this massive improvement in signa l collec- tion, and you can use it in diœerent ways depending on the task at hand." A GAME CHANGER IN CARING FOR PATIENTS? The impact of EX PLOR ER on the way clinicia ns detect a nd assess ca ncer, as well a s eva luate the success of onco- log ic therapies, could be tremendous. The machine may be able to identif y sma ller, less active lesions a nd a llow cl i n ici a n s t o be more def i n it ive i n t heir judg ments of treatments' ef f i- cacy, accord i ng to Ba daw i . He says E X PL OR E R m ay a l s o e l i m i n a t e a common problem of PET. "Breathing motion is the single most impor ta nt degrading factor in terms of spatia l accuracy when sca nning the t hora x," Badaw i says. " If you [cou ld s c a n a pat ient] i n 3 0 s e c ond s , you c ou ld do a breath-hold PET." A fa ster sca n wou ld be especia l ly important for the pediatric population. " You ca n reduce the need for a nes- thesia or even do away with it in some cases if you sca n fast enough," Badawi says. "[Children] a re more susceptible to ra d iation dose [t ha n a du lt s], but a nesthesia itself a lso ca rries sig nif i- ca nt risks — more so tha n radiation. If you could obviate the need for anesthe- sia in even a fraction of the pediatric population, that would be a big dea l." Jacobs, with NCI, cautions that the dev ice faces yea rs of study before it enters clinica l ca re. "I'd expect the clinica l efficacy tria ls to beg in in about four to f ive yea rs ... in pa ra llel with engineering effor ts to bring it to practica l a nd cost-effective ma nufacturing, fol lowed by g radua l expa nsion of ava ilabilit y over the fol- lowing years," she says. "If the increase in throughput and qua lity are rea lized, both patient ca re a nd hea lthca re costs will benef it." ■ SPECIAL CLINICAL SECTION: ONCOLOGY 1 9 M D N E W S .C O M /// M D N E W S L O W E R H U D S O N / B R O N X ■ 2 017

